6-K ·Filed May 11, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Leadership changes are routine and typically neutral. Monitor upcoming quarterly results for any strategic shifts or operational updates under the new CEO.
Final — all horizons settled through T+60d ⚠ clustered
BHST ▼ -34.64% at T+60d
NEUTRAL call -34.64% · α vs SPY -39.02% · entry $3.84 → $2.51
T+1d
0.00%
call 0.00% · α -0.54%
$3.84
settled 6mo ago
T+5d
+3.13%
call +3.13% · α +3.05%
$3.96
settled 5mo ago
T+20d
-19.53%
call -19.53% · α -17.80%
$3.09
settled 5mo ago
T+60d
-34.64%
call -34.64% · α -39.02%
$2.51
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
BioHarvest Sciences announced a strategic leadership transition: Co-Founder and Executive Chairman Zaki Rakib succeeds Ilan Sobel as CEO, with Sobel moving to the Board. The change aims to sharpen execution across the D2C and CDMO businesses. No financial details or guidance were provided in the filing.
Key Facts
- Zaki Rakib appointed CEO, effective April 29, 2026.
- Ilan Sobel transitions from CEO to Board member, focusing on D2C business.
- Rakib previously led CDMO and R&D; co-founded BioHarvest and former CEO of Terayon.
- FY2025 revenue mentioned as approximately $35M (from material change report).
Financial Impact
No direct financial impact; revenue mentioned as ~$35M for FY2025.
Risk Factors
- Execution risk from leadership transition.
- Potential strategic pivot may not materialize as expected.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001723464-26-000020 |
| Document: bhsc_ex991.htm | 0001723464-26-000020 |
| Document: 0001723464-26-000020-index-headers.html | 0001723464-26-000020 |
| Document: 0001723464-26-000020-index.html | 0001723464-26-000020 |
| Document: 0001723464-26-000020.txt | 0001723464-26-000020 |
14 reports for BHST
67% Hit rate @ T+5 Went positive at some point 2 of 3 best @ T+60▲ +49.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.75 $1.67 | ▼ −4.18% | ▼ −4.64% | $1.68 (−3.72%) |
Oct 8, 2026 18d ago | 6-K | $1.50 $1.70 | ▲ +13.71% | ▲ +13.99% | $1.68 (+12.37%) |
Sep 15, 2026 5w ago | 6-K | $1.66 $1.46 | ▼ −12.05% | ▼ −14.61% | $1.68 (+1.20%) |
Sep 14, 2026 6w ago | 6-K | $1.78 $1.51 | ▼ −14.93% | ▼ −17.04% | $1.68 (−5.35%) |
Jul 15, 2026 14w ago | 6-K | $2.85 $2.18 | ▼ −23.51% | ▼ −22.53% | $1.68 (−41.05%) |
Jun 18, 2026 18w ago | 6-K | $3.26 $2.75 | ▼ −15.64% | ▼ −13.98% | $1.68 (−48.47%) |
May 28, 2026 21w ago | 6-K | $3.90 $3.56 | ▼ −8.72% | ▼ −8.67% | $1.68 (−56.92%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▲ +8.17% | ▲ +7.46% | $1.68 (+59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 1h 49m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers